A massive power outage struck the Iberian Peninsula on Monday, affecting millions of people across Spain and Portugal and causing widespread disruption to essential services.

On tap for release this week are data on consumer confidence and nonfarm payrolls for April, along with first-quarter GDP growth ...

Pony AI shares jumped after the company said cost-cutting efforts are bringing it closer to profitability. The stock gained half its value Monday, hitting $10.54, and continuing a 132% run up over the ...

The Magnificent Seven tech stocks, once the leaders of the stock market's bull run, are solidly in the red this year. The ...

The Magnificent Seven tech giants are off to their worst start to a year since 2022, according to The Wall Street Journal.

Find insights on Alphabet, Deliveroo, Kuaishou, and more in the latest Market Talks covering the technology, media and ...

Only one group of stocks has come out on top in Donald Trump’s second term. The S&P 500 Consumer Staples sector is the only ...

President Donald Trump could be setting up Fed Chair Jerome Powell as a 'scapegoat' if a recession hits, according to an MSU ...

A report Friday said sentiment among U.S. consumers sank in April, though not by as much as economists expected. The survey ...

Nearly a hundred days into his second term, the Hearst Television Data Team analyzed movements in inflation and the stock ...

The stock and bond markets are awaiting news on trade deals as the Dow, S&P 500 and Nasdaq Composite look to build on last ...

Alnylam Pharmaceuticals said its RNAi therapeutic vutrisiran received a positive opinion recommending approval from the Committee for Medicinal Products for Human Use of the European Medicines Agency.